Recursion Pharmaceuticals... (RXRX)
NASDAQ: RXRX
· Real-Time Price · USD
4.79
0.25 (5.51%)
At close: Sep 11, 2025, 9:52 AM
Recursion Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for RXRX stock have an median target of 7, with a low estimate of 5 and a high estimate of 10. The median target predicts an increase of 46.14% from the current stock price of 4.79.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 5 | 7.25 | 7 | 10 |
| Change | 4.38% | 51.36% | 46.14% | 108.77% |
Latest Analyst Insight Report
Needham has reaffirmed a Buy rating for Recursion ... Unlock content with Pro Subscription
Updated Jul 08, 2025
| Rating | Jan 25 | Feb 25 | Apr 25 | May 25 | Jun 25 | Jul 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 1 |
| Hold | 0 | 1 | 1 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 1 | 1 | 2 |
Financial Forecast this Year
Revenue This Year
71.2M
from 58.84M
Increased by 21.0%
Revenue Next Year
100.09M
from 71.2M
Increased by 40.6%
EPS This Year
-1.58
from -1.69
Increased by 6.5%
EPS Next Year
-1.28
from -1.58
Increased by 19.0%